HU9400420D0 - Preparation of medicaments the peptidoglycan monomer or its derivatives - Google Patents

Preparation of medicaments the peptidoglycan monomer or its derivatives

Info

Publication number
HU9400420D0
HU9400420D0 HU9400420A HU9400420A HU9400420D0 HU 9400420 D0 HU9400420 D0 HU 9400420D0 HU 9400420 A HU9400420 A HU 9400420A HU 9400420 A HU9400420 A HU 9400420A HU 9400420 D0 HU9400420 D0 HU 9400420D0
Authority
HU
Hungary
Prior art keywords
medicaments
derivatives
preparation
peptidoglycan monomer
peptidoglycan
Prior art date
Application number
HU9400420A
Other languages
English (en)
Inventor
Bozidar Suskovic
Biserka Radosevic-Stasic
Danijel Rukavina
Radmila Naumski
Original Assignee
Pliva Pharm & Chem Works
Pliva Handels Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works, Pliva Handels Gmbh filed Critical Pliva Pharm & Chem Works
Publication of HU9400420D0 publication Critical patent/HU9400420D0/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU9400420A 1991-08-15 1992-08-13 Preparation of medicaments the peptidoglycan monomer or its derivatives HU9400420D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU141291 1991-08-15

Publications (1)

Publication Number Publication Date
HU9400420D0 true HU9400420D0 (en) 1994-08-29

Family

ID=25554075

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9400420A HU9400420D0 (en) 1991-08-15 1992-08-13 Preparation of medicaments the peptidoglycan monomer or its derivatives

Country Status (10)

Country Link
EP (1) EP0600974A1 (hu)
JP (1) JPH08506796A (hu)
BG (1) BG98628A (hu)
CA (1) CA2115270A1 (hu)
CZ (1) CZ30194A3 (hu)
HR (1) HRP920488A2 (hu)
HU (1) HU9400420D0 (hu)
RU (1) RU94027699A (hu)
SK (1) SK17994A3 (hu)
WO (1) WO1993003746A1 (hu)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8611982A8 (en) * 1986-11-19 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-acethyl-glucosisaminyl-N-acethyl- muramoil-L-alanyl-D-izoglutaminyl-(L)-mezodiaminopimelyl-(D-amid)- (L)-alanyl-D-alanine
US4868155A (en) * 1987-10-05 1989-09-19 Merck & Co., Inc. Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts
YU62689A (en) * 1989-03-27 1991-02-28 Pliva Pharm & Chem Works N-acyl derivatives of peptidoglican monomer, their pharmaceutically acceptable salts, process for preparing thereof and their use as immunity modulators and immunoadjuvant

Also Published As

Publication number Publication date
CA2115270A1 (en) 1993-03-04
JPH08506796A (ja) 1996-07-23
RU94027699A (ru) 1996-04-10
SK17994A3 (en) 1994-08-10
CZ30194A3 (en) 1994-06-15
EP0600974A1 (en) 1994-06-15
HRP920488A2 (en) 1994-08-31
BG98628A (en) 1995-06-30
WO1993003746A1 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
IL102777A0 (en) Pharmaceutical combination formulation
HU912801D0 (en) Isolated medicine proportioner
GB2255503B (en) Improved use of ß2-bronchodilator drugs
IL103303A0 (en) Medicament
AU1330392A (en) Safety syringe
GB9114950D0 (en) Pharmaceutical formulation
IL89502A0 (en) Plantinum derivatives and pharmaceutical compositions containing the same
GB9319494D0 (en) Pharmaceutical xanthone derivatives
GB9121463D0 (en) Medicament
AU1189392A (en) Pharmaceutical agent
EP0650723A3 (en) New pharmaceutical uses of forskolin derivatives.
HUT70031A (en) Alfa, omega-diarylalkane derivatives, their preparation and pharmaceutical compositions containing them
IL99454A0 (en) Monosaccharide derivatives and pharmaceutical compositions containing the same
AU2493792A (en) Pharmaceutical preparation
GB9216061D0 (en) Pharmaceutical combination formulation
CZ87895A3 (en) Pharmaceutical preparation
HU9400420D0 (en) Preparation of medicaments the peptidoglycan monomer or its derivatives
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
IL95760A0 (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing the same
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines
GB9206062D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use
GB9000241D0 (en) Pharmaceutical use
AU1103092A (en) Immunopotentiating drug
NZ248197A (en) 21-chloro-pregnane derivatives, preparation, use, and pharmaceutical compositions thereof
PL298159A1 (en) Pharmaceutical preparation